BALPHARMANSEBal Pharma Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 4 Apr · 12:00 IST

Bal Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Bal Pharma Limited has submitted a compliance certificate to the Exchange under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation requires the company's Registrar and Transfer Agent to confirm that securities received for dematerialization have been listed on the stock exchange. Such certificates are filed routinely after processing requests for converting physical share certificates into electronic (demat) form. No financial numbers, board decisions, or material events are mentioned in this filing.

Likely market impact

This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. Investors should view it as standard housekeeping rather than meaningful news.